Pioneering Cancer Gene Therapy Approved and Costs $475,000

Pioneering Cancer Gene Therapy Approved and Costs $475,000
Novartis via AP

The country's first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced.

 



Comment
Show comments Hide Comments


Related Articles